Holland Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$37.7M Sell
424,559
-19,444
-4% -$1.64M 1.65% 24
2017
Q1
$35.8M Sell
444,003
-44,390
-9% -$3.47M 1.53% 25
2016
Q4
$34.8M Sell
488,393
-20,348
-4% -$1.6M 1.46% 30
2016
Q3
$44M Sell
508,741
-142,149
-22% -$12.4M 1.8% 22
2016
Q2
$56.5M Sell
650,890
-656,512
-50% -$53.1M 2.19% 17
2016
Q1
$98.1M Sell
1,307,402
-173,304
-12% -$13.1M 2.6% 13
2015
Q4
$114M Sell
1,480,706
-47,411
-3% -$3.57M 2.93% 10
2015
Q3
$102M Sell
1,528,117
-102,372
-6% -$7.54M 2.66% 11
2015
Q2
$121M Sell
1,630,489
-84,392
-5% -$6.45M 2.87% 11
2015
Q1
$134M Sell
1,714,881
-71,632
-4% -$5.43M 3.03% 9
2014
Q4
$129M Buy
1,786,513
+517,841
+41% +$36M 2.96% 10
2014
Q3
$78.6M Buy
+1,268,672
New +$80.7M 1.7% 29

Other funds holding MDT

Holland Capital Management's MDT Position: Q2 2017 in Review

Holland Capital Management reduced its Medtronic (MDT) stake by 4.4% in Q2 2017, selling an estimated $1.64M and leaving 424,559 shares worth $37.7M. The position accounts for 1.65% of the portfolio, ranked #24.

Holland Capital Management first reported a position in MDT in Q3 2014 and has held it in 12 quarters since. The position peaked at $134M in Q1 2015. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Holland Capital Management held 424,559 shares of Medtronic worth $37.7M as of Q2 2017.
  • Holland Capital Management sold 19,444 Medtronic shares in Q2 2017, an estimated $1.64M.
  • Medtronic made up 1.65% of Holland Capital Management's portfolio in Q2 2017, its #24 holding.
  • Holland Capital Management first reported a position in Medtronic in Q3 2014 and has held it in 12 quarters since.
  • Holland Capital Management's Medtronic position peaked at $134M in Q1 2015.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Holland Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.